XML 67 R56.htm IDEA: XBRL DOCUMENT v3.26.1
EQUITY METHOD INVESTMENTS - Summary of the operating results for Paragon (Details) - USD ($)
$ in Thousands
 3 Months Ended 4 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2026
Jun. 30, 2026
Jun. 30, 2025
Schedule of Equity Method Investments [Line Items]            
Revenue $ 59,234   $ 46,700   $ 133,283 $ 82,396
Other operating expenses (12,375)   (15,656)   (2,628) (33,366)
Other expenses (1,441)   7,050   (7,941) 8,627
Net income (loss) 9,606   3,040   42,985 (3,230)
Change in foreign currency translation adjustments (3)       21  
Comprehensive income (loss) $ 9,603   $ 3,040   43,006 $ (3,230)
Paragon Advanced Labs Inc.            
Schedule of Equity Method Investments [Line Items]            
Net income (loss)   $ (660)   $ (999) (999)  
Change in foreign currency translation adjustments   (3)   21 $ 21  
Comprehensive income (loss)   (663)   (978)    
Paragon Advanced Labs Inc.            
Schedule of Equity Method Investments [Line Items]            
Subsidiary (as a percent) 100.00%       100.00%  
Revenue   1,608   1,920    
Production costs applicable to sales   (1,804)   (2,395)    
Gross profit   (196)   (475)    
Other operating expenses   (2,701)   (3,450)    
Other expenses   452   221    
Net income (loss)   (2,445)   (3,704)    
Change in foreign currency translation adjustments   (12)   78    
Comprehensive income (loss)   $ (2,457)   $ (3,625)